EP2962690

AMGEN EUROPE
Application Number
EP15177140A
Filing Date
Mar 20, 2003
Status
Revoked
Jan 22, 2025
Grant Date
Jan 16, 2019
External Links
Slate, Register, Google Patents
Similar Patents facing opposition

Bibliography

The patent EP2962690B1 was granted to Amgen Europe on Jan 16, 2019 following the initial filing on Mar 20, 2003 under the application number EP15177140A . The current legal status of the patent is Revoked.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions filed by Competitors

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

ALFRED E TIEFENBACHEROct 16, 2019ADMISSIBLE
CIPLAOct 16, 2019ADMISSIBLE
DR REDDYS LABORATORIESOct 16, 2019ADMISSIBLE
GALENICUM HEALTH SLUOct 16, 2019ADMISSIBLE
KRKAOct 16, 2019ADMISSIBLE
STADA ARZNEIMITTELOct 16, 2019ADMISSIBLE
ZENTIVA KSOct 16, 2019ADMISSIBLE
HEXALOct 15, 2019ADMISSIBLE
QUIMICA SINTETICAOct 15, 2019ADMISSIBLE
SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETIOct 15, 2019ADMISSIBLE
GENERICS UKOct 11, 2019ADMISSIBLE
POLPHARMAOct 11, 2019ADMISSIBLE
ACCORD HEALTHCAREOct 10, 2019ADMISSIBLE
HOFFMANN EITLEOct 10, 2019ADMISSIBLE
TEVA PHARMACEUTICALSOct 3, 2019ADMISSIBLE

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents